Updates
September 23, 2024
Drug Recalls: What You Need to Know
As patients, we take for granted that our medicines are safe and pure and that the side effects have been honestly disclosed to us so…
September 16, 2024
Update on Glenmark’s Recall of Potassium Chloride Extended-Release Capsules
The Block Firm’s investigation continues into Glenmark’s recall of tens of millions of potassium chloride extended-release capsules. Here is what we have learned so far…
September 3, 2024
The Block Firm Files Class Action Lawsuit Against Glenmark Pharmaceuticals
At The Block Firm, we are committed to holding drug companies accountable when they prioritize profits over patient safety. We recently filed a class action…
July 23, 2024
Glenmark Drug Recall: Potassium Chloride Extended Release Capsules
On June 24, 2024, the FDA published a recall of certain batches of Glenmark Pharmaceuticals’ Potassium Chloride Extended Release Capsules because they failed to meet the…
July 1, 2024
Breckenridge Duloxetine Recall Expands—Now Approximately 70 Million Pills
As The Block Firm previously revealed, Breckenridge Pharmaceutical, Inc. has recalled at least 50 million tablets of Duloxetine due to the presence of nitrosamines, potent…
June 4, 2024
Court Grants Final Approval to $46.5 Million Class Action Settlement
This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The…
May 30, 2024
The Block Firm Files Class Action About Contaminated Drugs
This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of…
May 17, 2024
FDA Recalls Duloxetine: The Block Firm continues to investigate
The U.S. Food and Drug Administration (FDA) has recently issued a recall for duloxetine, a medication commonly prescribed for depression and anxiety. If you or…
May 8, 2024
The Block Firm Investigates the Presence of Carcinogens in Duloxetine (Generic Cymbalta)
Millions of Americans take the drug duloxetine—a generic form of Cymbalta—for depression, pain, and anxiety. According to a recent FDA announcement, tens of millions of…
March 20, 2024
The Block Firm Investigates Unapproved Thyroid Drug, Adthyza
The Block Firm is investigating a new potential case regarding Adthyza, an unapproved thyroid drug manufactured by Azurity. At The Block Firm, we believe that…
OUR PEOPLE
We’re here when you need us.
